Global Specific Cancer Immunotherapy Drugs Sales Market Report 2017

特定癌免疫療法薬の世界市場:販売動向2017

◆タイトル:Global Specific Cancer Immunotherapy Drugs Sales Market Report 2017
◆商品コード:QYR7054512
◆調査・発行会社:QYResearch
◆発行日:2017年4月11日
◆ページ数:131
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,099 ⇒換算¥459,088見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD8,198 ⇒換算¥918,176見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、特定癌免疫療法薬の世界市場について調査・分析し、特定癌免疫療法薬のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、特定癌免疫療法薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・特定癌免疫療法薬市場概要
・特定癌免疫療法薬のメーカー別販売量・メーカー別シェア
・特定癌免疫療法薬の世界市場:種類別販売量・市場シェア
・特定癌免疫療法薬の世界市場:用途別販売量・市場シェア
・特定癌免疫療法薬の世界市場:地域別販売量・市場シェア
・特定癌免疫療法薬のアメリカ市場規模
・特定癌免疫療法薬の中国市場規模
・特定癌免疫療法薬のヨーロッパ市場規模
・特定癌免疫療法薬の日本市場規模
・特定癌免疫療法薬の東南アジア市場規模
・特定癌免疫療法薬のインド市場規模
・特定癌免疫療法薬のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・特定癌免疫療法薬のコスト分析・価格動向
・特定癌免疫療法薬の産業チェーン(サプライチェーン分析)
・特定癌免疫療法薬のマーケティング戦略・販売チャネル、流通業者
・特定癌免疫療法薬市場への影響要因分析
・特定癌免疫療法薬の世界市場予測
・特定癌免疫療法薬のアメリカ市場予測
・特定癌免疫療法薬の中国市場予測
・特定癌免疫療法薬のヨーロッパ市場予測
・特定癌免疫療法薬の日本市場予測
・特定癌免疫療法薬の東南アジア市場予測
・特定癌免疫療法薬のインド市場予測
・特定癌免疫療法薬の種類別世界市場予測
・特定癌免疫療法薬の用途別世界市場予測
...

On the basis of product, the Specific Cancer Immunotherapy Drugs market is primarily split into
Monoclonal Antibodies
Vaccines
Check Point Inhibitors
Cell Therapies
Immunomodulators

On the basis on the end users/applications, this report covers
Lung Cancer
Breast Cancer
Multiple Myeloma
Colorectal Cancer
Head & Neck Cancer
Prostate Cancer
Melanoma
Other Cancer

【レポートの目次】

Table of Contents

Global Specific Cancer Immunotherapy Drugs Sales Market Report 2017
1 Methodology/Research Approach
1.1 Research Programs/Design
1.2 Market Size Estimation
1.3 Market Breakdown and Data Triangulation
2 Data Source
2.1 Secondary Sources
2.2 Primary Sources
3 Disclaimer
1 Specific Cancer Immunotherapy Drugs Market Overview
1.1 Product Overview and Scope of Specific Cancer Immunotherapy Drugs
1.2 Classification of Specific Cancer Immunotherapy Drugs by Product Category
1.2.1 Global Specific Cancer Immunotherapy Drugs Sales and Growth (%) Comparison by Types (Product Category) (2012-2022)
1.2.2 Global Specific Cancer Immunotherapy Drugs Sales Market Share (%) by Types (Product Category) in 2016
1.2.3 Monoclonal Antibodies
1.2.4 Vaccines
1.2.5 Check Point Inhibitors
1.2.6 Cell Therapies
1.2.7 Immunomodulators
1.3 Global Specific Cancer Immunotherapy Drugs Market by Applications/End Users
1.3.1 Global Specific Cancer Immunotherapy Drugs Sales (K Ton) Comparison by Applications (2012-2022)
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Multiple Myeloma
1.3.5 Colorectal Cancer
1.3.6 Head & Neck Cancer
1.3.7 Prostate Cancer
1.3.8 Melanoma
1.3.9 Other Cancer
1.4 Global Specific Cancer Immunotherapy Drugs Market by Regions
1.4.1 Global Specific Cancer Immunotherapy Drugs Revenue (Million USD) Comparison by Regions (2012-2022)
1.4.2 United States Specific Cancer Immunotherapy Drugs Status and Prospect (2012-2022)
1.4.3 China Specific Cancer Immunotherapy Drugs Status and Prospect (2012-2022)
1.4.4 Europe Specific Cancer Immunotherapy Drugs Status and Prospect (2012-2022)
1.4.5 Japan Specific Cancer Immunotherapy Drugs Status and Prospect (2012-2022)
1.4.6 Southeast Asia Specific Cancer Immunotherapy Drugs Status and Prospect (2012-2022)
1.4.7 India Specific Cancer Immunotherapy Drugs Status and Prospect (2012-2022)
1.5 Global Specific Cancer Immunotherapy Drugs Sales and Revenue (2012-2022)
1.5.1 Global Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (%) (2012-2022)
1.5.2 Global Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
2 Global Specific Cancer Immunotherapy Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Specific Cancer Immunotherapy Drugs Market Competition by Players/Suppliers
2.1.1 Global Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) of Key Players/Suppliers (2012-2017)
2.1.2 Global Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017)
2.2 Global Specific Cancer Immunotherapy Drugs Sales and Revenue by Type
2.2.1 Global Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Type (2012-2017)
2.2.2 Global Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Market Share (%) by Type (2012-2017)
2.3 Global Specific Cancer Immunotherapy Drugs Sales and Revenue by Regions
2.3.1 Global Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Regions (2012-2017)
2.3.2 Global Specific Cancer Immunotherapy Drugs Revenue and Market Share (%) by Regions (2012-2017)
2.4 Global Specific Cancer Immunotherapy Drugs Sales by Application
3 USA Specific Cancer Immunotherapy Drugs (Sales, Revenue and Price)
3.1 USA Specific Cancer Immunotherapy Drugs Sales and Revenue (2012-2017)
3.1.1 USA Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (%) (2012-2017)
3.1.2 USA Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
3.1.3 USA Specific Cancer Immunotherapy Drugs Price (USD/Kg) Trend (2012-2017)
3.2 USA Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Players
3.3 USA Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Type
3.4 USA Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Applications
4 China Specific Cancer Immunotherapy Drugs (Sales, Revenue and Price)
4.1 China Specific Cancer Immunotherapy Drugs Sales and Revenue (2012-2017)
4.1.1 China Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (2012-2017)
4.1.2 China Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
4.1.3 China Specific Cancer Immunotherapy Drugs Price (USD/Kg) Trend (2012-2017)
4.2 China Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Players
4.3 China Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Type
4.4 China Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Applications
5 Europe Specific Cancer Immunotherapy Drugs (Sales, Revenue and Price)
5.1 Europe Specific Cancer Immunotherapy Drugs Sales (K Ton) and Value (2012-2017)
5.1.1 Europe Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (2012-2017)
5.1.2 Europe Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
5.1.3 Europe Specific Cancer Immunotherapy Drugs Price (USD/Kg) Trend (2012-2017)
5.2 Europe Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Players
5.3 Europe Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Type
5.4 Europe Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Applications
6 Japan Specific Cancer Immunotherapy Drugs (Sales, Revenue and Price)
6.1 Japan Specific Cancer Immunotherapy Drugs Sales (K Ton) and Value (2012-2017)
6.1.1 Japan Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (2012-2017)
6.1.2 Japan Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
6.1.3 Japan Specific Cancer Immunotherapy Drugs Price (USD/Kg) Trend (2012-2017)
6.2 Japan Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Players
6.3 Japan Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Type
6.4 Japan Specific Cancer Immunotherapy Drugs Sales and Market Share (%) by Applications
7 India Specific Cancer Immunotherapy Drugs (Sales, Revenue and Price)
7.1 India Specific Cancer Immunotherapy Drugs Sales (K Ton) and Value (2012-2017)
7.1.1 India Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (%) (2012-2017)
7.1.2 India Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
7.1.3 India Specific Cancer Immunotherapy Drugs Price (USD/Kg) Trend (2012-2017)
7.2 India Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Players
7.3 India Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Type
7.4 India Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Applications
8 Southeast Asia Specific Cancer Immunotherapy Drugs (Sales, Revenue and Price)
8.1 Southeast Asia Specific Cancer Immunotherapy Drugs Sales (K Ton) and Value (2012-2017)
8.1.1 Southeast Asia Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (2012-2017)
8.1.2 Southeast Asia Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
8.1.3 Southeast Asia Specific Cancer Immunotherapy Drugs Price (USD/Kg) Trend (2012-2017)
8.2 Southeast Asia Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Players
8.3 Southeast Asia Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Type
8.4 Southeast Asia Specific Cancer Immunotherapy Drugs Sales and Market Share (%) by Applications
9 Global Specific Cancer Immunotherapy Drugs Players/Suppliers Profiles and Sales Data
9.1 Amgen Inc.
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Specific Cancer Immunotherapy Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Amgen Inc. Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Astrazeneca
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Specific Cancer Immunotherapy Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Astrazeneca Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Bayer AG
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Specific Cancer Immunotherapy Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Bayer AG Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Bristol-Myers Squibb
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Specific Cancer Immunotherapy Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Bristol-Myers Squibb Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Eli Lilly and Company
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Specific Cancer Immunotherapy Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Eli Lilly and Company Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Janssen Global Services, LLC (Johnson and Johnson)
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Specific Cancer Immunotherapy Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Janssen Global Services, LLC (Johnson and Johnson) Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Merck
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Specific Cancer Immunotherapy Drugs Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Merck Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Novartis
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Specific Cancer Immunotherapy Drugs Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Novartis Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Pfizer
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Specific Cancer Immunotherapy Drugs Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Pfizer Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
9.9.4 Main Business/Business Overview
9.10 F. Hoffmann-LA Roche Ltd
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Specific Cancer Immunotherapy Drugs Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 F. Hoffmann-LA Roche Ltd Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
9.10.4 Main Business/Business Overview
10 Specific Cancer Immunotherapy Drugs Manufacturing Cost Analysis
10.1 Specific Cancer Immunotherapy Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Expenses
10.3 Manufacturing Process Analysis of Specific Cancer Immunotherapy Drugs
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Specific Cancer Immunotherapy Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Specific Cancer Immunotherapy Drugs Major Players in 2016
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Specific Cancer Immunotherapy Drugs Market Forecast (2017-2022)
14.1 Global Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue and Price Forecast (2017-2022)
14.1.1 Global Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate Forecast (2017-2022)
14.1.2 Global Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
14.1.3 Global Specific Cancer Immunotherapy Drugs Price (USD/Kg) and Trend Forecast (2017-2022)
14.2 Global Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD) and Growth Rate Forecast by Regions (2017-2022)
14.2.1 Global Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate Forecast by Regions (2017-2022)
14.2.3 USA Specific Cancer Immunotherapy Drugs Sales, Revenue (Million USD) and Growth Rate Forecast (2017-2022)
14.2.4 Europe Specific Cancer Immunotherapy Drugs Sales, Revenue (Million USD) and Growth Rate Forecast (2017-2022)
14.2.5 China Specific Cancer Immunotherapy Drugs Sales, Revenue (Million USD) and Growth Rate Forecast (2017-2022)
14.2.6 Japan Specific Cancer Immunotherapy Drugs Sales, Revenue (Million USD) and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Specific Cancer Immunotherapy Drugs Sales, Revenue (Million USD) and Growth Rate Forecast (2017-2022)
14.2.8 India Specific Cancer Immunotherapy Drugs Sales, Revenue (Million USD) and Growth Rate Forecast (2017-2022)
14.3 Global Specific Cancer Immunotherapy Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Specific Cancer Immunotherapy Drugs Sales Forecast by Type (2017-2022)
14.3.2 Global Specific Cancer Immunotherapy Drugs Revenue Forecast by Type (2017-2022)
14.3.2 Global Specific Cancer Immunotherapy Drugs Price Forecast by Type (2017-2022)
14.4 Global Specific Cancer Immunotherapy Drugs Sales Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Analyst Introduction
16.3 Data Source

List of Tables and Figures

Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Product Picture of Specific Cancer Immunotherapy Drugs
Table Global Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Specific Cancer Immunotherapy Drugs Sales Market Share (%) by Types (Product Category) in 2016
Figure Monoclonal Antibodies Product Picture
Figure Vaccines Product Picture
Figure Check Point Inhibitors Product Picture
Table Global Specific Cancer Immunotherapy Drugs Sales (K Ton) Comparison by Applications (2012-2022)
Figure Global Sales Market Share (%) of Specific Cancer Immunotherapy Drugs by Applications in 2016
Figure Lung Cancer Examples
Figure Breast Cancer Examples
Figure Multiple Myeloma Examples
Figure Colorectal Cancer Examples
Figure Head & Neck Cancer Examples
Figure Global Specific Cancer Immunotherapy Drugs Revenue (Million USD) Comparison by Regions (2012-2022)
Figure United States Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (2012-2022)
Figure Global Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Table Global Specific Cancer Immunotherapy Drugs Sales (K Ton) of Key Players/Suppliers (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Sales Share (%) by Players/Suppliers (2012-2017)
Figure 2016 Global Specific Cancer Immunotherapy Drugs Sales Share (%) by Players/Suppliers
Figure 2017 Global Specific Cancer Immunotherapy Drugs Sales Share (%) by Players/Suppliers
Table Global Specific Cancer Immunotherapy Drugs Revenue by Players/Suppliers (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Revenue Share (%) by Players/Suppliers (2012-2017)
Figure 2016 Global Specific Cancer Immunotherapy Drugs Revenue Share (%) by Players
Figure 2017 Global Specific Cancer Immunotherapy Drugs Revenue Share (%) by Players
Table Global Specific Cancer Immunotherapy Drugs Sales (K Ton) by Type (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Sales Share (%) by Type (2012-2017)
Figure Sales Market Share (%) of Specific Cancer Immunotherapy Drugs by Type (2012-2017)
Figure Global Specific Cancer Immunotherapy Drugs Sales Growth Rate by Type (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Market Share (%) by Type (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Revenue Share (%) by Type (2012-2017)
Figure Revenue Market Share (%) of Specific Cancer Immunotherapy Drugs by Type (2012-2017)
Figure Global Specific Cancer Immunotherapy Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Regions (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Sales Share (%) by Regions (2012-2017)
Figure Sales Market Share (%) of Specific Cancer Immunotherapy Drugs by Regions (2012-2017)
Figure Global Specific Cancer Immunotherapy Drugs Sales Market Share (%) by Regions in 2016
Table Global Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Market Share (%) by Regions (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Revenue Share (%) by Regions (2012-2017)
Figure Revenue Market Share (%) of Specific Cancer Immunotherapy Drugs by Regions (2012-2017)
Figure Global Specific Cancer Immunotherapy Drugs Revenue Market Share (%) by Regions in 2016
Table Global Specific Cancer Immunotherapy Drugs Sales (K Ton) and Market Share (%) by Application (2012-2017)
Table Global Specific Cancer Immunotherapy Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share (%) of Specific Cancer Immunotherapy Drugs by Application (2012-2017)
Figure Global Specific Cancer Immunotherapy Drugs Sales Market Share (%) by Application (2012-2017)
Figure USA Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (%) (2012-2017)
Figure USA Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure USA Specific Cancer Immunotherapy Drugs Price (USD/Kg) Trend (2012-2017)
Table USA Specific Cancer Immunotherapy Drugs Sales (K Ton) by Players (2012-2017)
Table USA Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Players (2012-2017)
Figure USA Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Players in 2016
Table USA Specific Cancer Immunotherapy Drugs Sales (K Ton) by Type (2012-2017)
Table USA Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Type (2012-2017)
Figure USA Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Type in 2016
Table USA Specific Cancer Immunotherapy Drugs Sales (K Ton) by Applications (2012-2017)
Table USA Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Applications (2012-2017)
Figure USA Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Applications in 2016
Figure China Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (2012-2017)
Figure China Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Specific Cancer Immunotherapy Drugs Price (USD/Kg) Trend (2012-2017)
Table China Specific Cancer Immunotherapy Drugs Sales (K Ton) by Players (2012-2017)
Table China Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Players (2012-2017)
Figure China Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Players in 2016
Table China Specific Cancer Immunotherapy Drugs Sales (K Ton) by Type (2012-2017)
Table China Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Type (2012-2017)
Figure China Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Type in 2016
Table China Specific Cancer Immunotherapy Drugs Sales (K Ton) by Applications (2012-2017)
Table China Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Applications (2012-2017)
Figure China Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Applications in 2016
Figure Europe Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (2012-2017)
Figure Europe Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Specific Cancer Immunotherapy Drugs Price (USD/Kg) Trend (2012-2017)
Table Europe Specific Cancer Immunotherapy Drugs Sales (K Ton) by Players (2012-2017)
Table Europe Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Players (2012-2017)
Figure Europe Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Players in 2016
Table Europe Specific Cancer Immunotherapy Drugs Sales (K Ton) by Type (2012-2017)
Table Europe Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Type (2012-2017)
Figure Europe Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Type in 2016
Table Europe Specific Cancer Immunotherapy Drugs Sales (K Ton) by Applications (2012-2017)
Table Europe Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Applications (2012-2017)
Figure Europe Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Applications in 2016
Figure Japan Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (2012-2017)
Figure Japan Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Specific Cancer Immunotherapy Drugs Price (USD/Kg) Trend (2012-2017)
Table Japan Specific Cancer Immunotherapy Drugs Sales (K Ton) by Players (2012-2017)
Table Japan Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Players (2012-2017)
Figure Japan Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Players in 2016
Table Japan Specific Cancer Immunotherapy Drugs Sales (K Ton) by Type (2012-2017)
Table Japan Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Type (2012-2017)
Figure Japan Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Type in 2016
Table Japan Specific Cancer Immunotherapy Drugs Sales (K Ton) by Applications (2012-2017)
Table Japan Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Applications (2012-2017)
Figure Japan Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Applications in 2016
Figure India Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (2012-2017)
Figure India Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Specific Cancer Immunotherapy Drugs Price (USD/Kg) Trend (2012-2017)
Table India Specific Cancer Immunotherapy Drugs Sales (K Ton) by Players (2012-2017)
Table India Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Players (2012-2017)
Figure India Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Players in 2016
Table India Specific Cancer Immunotherapy Drugs Sales (K Ton) by Type (2012-2017)
Table India Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Type (2012-2017)
Figure India Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Type in 2016
Table India Specific Cancer Immunotherapy Drugs Sales (K Ton) by Applications (2012-2017)
Table India Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Applications (2012-2017)
Figure India Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Applications in 2016
Figure Southeast Asia Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (2012-2017)
Figure Southeast Asia Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Specific Cancer Immunotherapy Drugs Price (USD/Kg) Trend (2012-2017)
Table Southeast Asia Specific Cancer Immunotherapy Drugs Sales (K Ton) by Players (2012-2017)
Table Southeast Asia Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Players (2012-2017)
Figure Southeast Asia Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Players in 2016
Table Southeast Asia Specific Cancer Immunotherapy Drugs Sales (K Ton) by Type (2012-2017)
Table Southeast Asia Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Type (2012-2017)
Figure Southeast Asia Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Type in 2016
Table Southeast Asia Specific Cancer Immunotherapy Drugs Sales (K Ton) by Applications (2012-2017)
Table Southeast Asia Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Applications (2012-2017)
Figure Southeast Asia Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) by Applications in 2016
Table Amgen Inc. Basic Information List
Table Amgen Inc. Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Figure Amgen Inc. Specific Cancer Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure Amgen Inc. Specific Cancer Immunotherapy Drugs Sales Global Market Share (%) (2012-2017)
Figure Amgen Inc. Specific Cancer Immunotherapy Drugs Revenue Global Market Share (%) (2012-2017)
Table Astrazeneca Basic Information List
Table Astrazeneca Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Figure Astrazeneca Specific Cancer Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure Astrazeneca Specific Cancer Immunotherapy Drugs Sales Global Market Share (%) (2012-2017)
Figure Astrazeneca Specific Cancer Immunotherapy Drugs Revenue Global Market Share (%) (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Figure Bayer AG Specific Cancer Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure Bayer AG Specific Cancer Immunotherapy Drugs Sales Global Market Share (%) (2012-2017)
Figure Bayer AG Specific Cancer Immunotherapy Drugs Revenue Global Market Share (%) (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Figure Bristol-Myers Squibb Specific Cancer Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Specific Cancer Immunotherapy Drugs Sales Global Market Share (%) (2012-2017)
Figure Bristol-Myers Squibb Specific Cancer Immunotherapy Drugs Revenue Global Market Share (%) (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Figure Eli Lilly and Company Specific Cancer Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Specific Cancer Immunotherapy Drugs Sales Global Market Share (%) (2012-2017)
Figure Eli Lilly and Company Specific Cancer Immunotherapy Drugs Revenue Global Market Share (%) (2012-2017)
Table Janssen Global Services, LLC (Johnson and Johnson) Basic Information List
Table Janssen Global Services, LLC (Johnson and Johnson) Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Figure Janssen Global Services, LLC (Johnson and Johnson) Specific Cancer Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure Janssen Global Services, LLC (Johnson and Johnson) Specific Cancer Immunotherapy Drugs Sales Global Market Share (%) (2012-2017)
Figure Janssen Global Services, LLC (Johnson and Johnson) Specific Cancer Immunotherapy Drugs Revenue Global Market Share (%) (2012-2017)
Table Merck Basic Information List
Table Merck Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Figure Merck Specific Cancer Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure Merck Specific Cancer Immunotherapy Drugs Sales Global Market Share (%) (2012-2017)
Figure Merck Specific Cancer Immunotherapy Drugs Revenue Global Market Share (%) (2012-2017)
Table Novartis Basic Information List
Table Novartis Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure Novartis Specific Cancer Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure Novartis Specific Cancer Immunotherapy Drugs Sales Global Market Share (%) (2012-2017)
Figure Novartis Specific Cancer Immunotherapy Drugs Revenue Global Market Share (%) (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Figure Pfizer Specific Cancer Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Specific Cancer Immunotherapy Drugs Sales Global Market Share (%) (2012-2017)
Figure Pfizer Specific Cancer Immunotherapy Drugs Revenue Global Market Share (%) (2012-2017)
Table F. Hoffmann-LA Roche Ltd Basic Information List
Table F. Hoffmann-LA Roche Ltd Specific Cancer Immunotherapy Drugs Sales (K Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Figure F. Hoffmann-LA Roche Ltd Specific Cancer Immunotherapy Drugs Sales Growth Rate (2012-2017)
Figure F. Hoffmann-LA Roche Ltd Specific Cancer Immunotherapy Drugs Sales Global Market Share (%) (2012-2017)
Figure F. Hoffmann-LA Roche Ltd Specific Cancer Immunotherapy Drugs Revenue Global Market Share (%) (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Specific Cancer Immunotherapy Drugs
Figure Manufacturing Process Analysis of Specific Cancer Immunotherapy Drugs
Figure Specific Cancer Immunotherapy Drugs Industrial Chain Analysis
Table Raw Materials Sources of Specific Cancer Immunotherapy Drugs Major Players in 2016
Table Major Buyers of Specific Cancer Immunotherapy Drugs
Table Distributors/Traders List
Figure Global Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate Forecast (2017-2022)
Figure Global Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Specific Cancer Immunotherapy Drugs Price (USD/Kg) and Trend Forecast (2017-2022)
Table Global Specific Cancer Immunotherapy Drugs Sales (K Ton) Forecast by Regions (2017-2022)
Figure Global Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) Forecast by Regions (2017-2022)
Figure Global Specific Cancer Immunotherapy Drugs Sales (K Ton) Market Share (%) Forecast by Regions in 2022
Table Global Specific Cancer Immunotherapy Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Specific Cancer Immunotherapy Drugs Revenue Market Share (%) Forecast by Regions (2017-2022)
Figure Global Specific Cancer Immunotherapy Drugs Revenue Market Share (%) Forecast by Regions in 2022
Figure USA Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (%) Forecast (2017-2022)
Figure USA Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Europe Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (%) Forecast (2017-2022)
Figure Europe Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (%) Forecast (2017-2022)
Figure China Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (%) Forecast (2017-2022)
Figure Japan Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (%) Forecast (2017-2022)
Figure Southeast Asia Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Specific Cancer Immunotherapy Drugs Sales (K Ton) and Growth Rate (%) Forecast (2017-2022)
Figure India Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Specific Cancer Immunotherapy Drugs Sales Forecast by Type (2017-2022)
Figure Global Specific Cancer Immunotherapy Drugs Sales Market Share (%) Forecast by Type (2017-2022)
Table Global Specific Cancer Immunotherapy Drugs Revenue Forecast by Type (2017-2022)
Figure Global Specific Cancer Immunotherapy Drugs Revenue Market Share (%) Forecast by Type (2017-2022)
Table Global Specific Cancer Immunotherapy Drugs Price Forecast by Type (2017-2022)
Table Global Specific Cancer Immunotherapy Drugs Sales Forecast by Application (2017-2022)
Figure Global Specific Cancer Immunotherapy Drugs Sales Market Share (%) Forecast by Application (2017-2022)



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[特定癌免疫療法薬の世界市場:販売動向2017] (Global Specific Cancer Immunotherapy Drugs Sales Market Report 2017 / QYR7054512)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆